Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT. - Wikidata - wikimedia - TriplyDB

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

http://www.wikidata.org/entity/Q37421288

about

The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor.Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: can we decide?Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization.Chemotherapy-Induced Neutropenia in HIV Positive Patients with Lymphoma: Comparison of Pegfilgrastim with Daily Filgrastim Administration Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation.Plerixafor and pegylated filgrastim: a case of safe and effective hematopoietic stem cell mobilization.Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly.

P2860

Q35041174-F8096916-7EB1-43FC-B0C6-DBB54AD1E403 Q35547153-A98E2106-A6A1-4E2E-A1D6-758B0ECA2234 Q35555633-FDDF8798-5B90-475B-AAA5-A8ED4A736834 Q37060682-AD57CB1A-ADE9-45C5-BD53-8D707ABD4D3B Q37432037-DD7E2EA9-8B57-4957-96D9-923455D23504 Q37950430-A6EE1362-6B46-441E-B788-4F7F6FABD204 Q38193590-D09D1725-975F-4E42-B088-2631E6D03312 Q41104478-55101679-30EF-47B9-B802-A3293004F746 Q42184785-FB2AA70D-759A-401B-A20D-665CEFA43789 Q43228481-8985459C-7779-47F9-A53B-4505AE4788AC Q47696715-43178403-B8F5-474A-BAE7-098B96BD182B

P2860

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

http://www.wikidata.org/entity/Q37421288

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@en

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@nl

type

label

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@en

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@nl

prefLabel

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@en

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@nl

P1433

Q37421288-744B4220-A4EE-4F88-AA41-B5F13E4B6CB2

P1476

Q37421288-4F22F50C-B675-4D1B-8D2B-F160B1A65E04

P2093

Q37421288-22930A10-1C53-413C-81BF-2C82F3EA81BE

Q37421288-7933470E-B9EA-4645-979A-5883BB32EF0D

Q37421288-C8AC43FC-6F02-433E-89C7-9519BFF5CA7D

Q37421288-DDB1F9C9-E979-42CC-AAF1-556D028F5DA6

Q37421288-FECB6200-A624-4A35-9570-4536452436DF

P2860

Q37421288-05C4FBF3-3516-4495-98F4-939AA0ED2EB8

Q37421288-11FC8F15-C07F-4C9C-BA63-DE372C2927ED

Q37421288-2909A269-80F2-4E18-B99A-CA05E5EE2DF5

Q37421288-3C79C180-181E-4AAC-9353-106F12E75013

Q37421288-46A2943D-53A0-4652-BF0D-FC309C9F06CF

Q37421288-47DA04DC-DC1D-46CA-9537-8FBC7F6E1B5A

Q37421288-48626D89-5077-4605-97CC-5665BC354951

Q37421288-48932773-F6FE-4AA4-81AD-D79A4CF9AFFC

Q37421288-662A2F8B-8445-4151-8542-91C88C7FE423

Q37421288-795B89AE-4539-4BDE-85CE-3E4D643165B1

P2888

Q37421288-81AF397F-E973-4C8A-B044-E2BD90E41AFD

P304

Q37421288-A53C6E8B-521E-481B-A022-F349AD29CEE3

P31

Q37421288-4171AF56-4C04-4321-A6AC-9F57A5427C41

P356

Q37421288-B5F5138E-4BBE-4A98-A12B-23250FC76EC2

P407

Q37421288-C34C9488-1C84-459B-AA3C-B83C57DD84E0

P433

Q37421288-ACFCDB90-080A-49F2-85BA-3EE13DA6A67E

P478

Q37421288-A50A76A0-7226-402B-8EB6-32E21229308B

P577

Q37421288-C5100DC0-1824-4789-B622-48485E33A0C4

P5875

Q37421288-52F0B079-23DF-4823-BB00-5D1DF7D0E8EA

P698

Q37421288-568EAB2D-709C-41C7-8186-CECA322F0B4E

P356

P1433

Bone Marrow Transplantation

P1476

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

@en

P2093

A Czibere

http://www.w3.org/2001/XMLSchema#string

G Kobbe

http://www.w3.org/2001/XMLSchema#string

I Bruns

http://www.w3.org/2001/XMLSchema#string

R Fenk

http://www.w3.org/2001/XMLSchema#string

R Haas

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma.

Management strategies for the hard-to-mobilize patient.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Pegfilgrastim: evidence in support of its use with cytotoxic chemotherapy.

Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?

Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.

Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas.

Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.

Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.

P2888

P304

669-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2009.59

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24221284

http://www.w3.org/2001/XMLSchema#string

P698

19308043

http://www.w3.org/2001/XMLSchema#string